Slide 1: Earnings Call: Q2 - FY26
Earnings Call: Q2 - FY26 April 9, 2026 Nasdaq: SLP
Slide 2: Safe Harbor Statement
Safe Harbor Statement Except for historical information, the matters discussed in this presentation are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, that involve risks and uncertainties. Words like “believe,” “will”, “can”, “expect,” “anticip
Slide 3: Second Quarter 2026 Highlights
Second Quarter 2026 Highlights Current period $24.3M +8% $0.22 $0.35 36% Revenue Revenue Diluted EPS Adj. Adj. EBITDA Growth Diluted EPS Margin Prior Year Comparison (2Q25) $22.4M +23% $0.15 $0.31 29% Revenue Revenue Diluted EPS Adj. Adj. EBITDA Growth Diluted EPS Margin 2
Slide 4: Trailing Twelve Months (TTM) Highlights
Trailing Twelve Months (TTM) Highlights Current period $80.5M +3% ($3.12) $1.02 29% Revenue Revenue Diluted EPS (1) Adj. Adj. EBITDA Growth Diluted EPS Margin Prior Year Comparison (2Q25) $78.6M +21% $0.36 $0.93 26% Revenue Revenue Diluted EPS Adj. Adj. EBITDA Growth Diluted EPS Margin (1) Diluted E
Slide 5: Software Highlights
Software Highlights – Overall software revenue growth of 9% for 2Q26 and -2% for TTM – Renewal rates impacted by client consolidations and site closures Pro-ficiency® CLINICAL OPS +18% 12% -54% Q2 Revenue Growth Q2 Revenue Growth Q2 Revenue Decline $18.7M $0.04 22% +6% Revenue 3% EPS Diluted -58% Ad
Slide 6: Services Highlights
Services Highlights – Overall services revenue growth of 8% for 2Q26 and 9% for TTM – Total backlog $24.0M Med Comm Services COMMERCIALIZATION +12% -1% Q2 Revenue Q2 Revenue Growth Decline $18.7M +19% $0.04 $0.18 22% Revenue -3% Revenue Growth Diluted EPS Adj. Diluted EPS +66% Adj. EBITDA Margin TTM
Slide 7: Revenue - Q2 FY26
Revenue - Q2 FY26 (in millions) 2Q26 Mix +8% +9% +8% Total Revenue Software Revenue Services Revenue Growth Growth Growth 2Q25 Mix 6
Slide 8: Revenue - YTD FY26
Revenue - YTD FY26 (in millions) FY26 Mix +3% -3% +12% Total Revenue Software Revenue Services Revenue Growth Decline Growth FY25 Mix 7
Slide 9: Revenue - Trailing Twelve Months (TTM)
Revenue - Trailing Twelve Months (TTM) (in millions) 2Q26 Mix +3% -2% +9% Total Revenue Software Revenue Services Revenue Growth Growth Growth 2Q25 Mix 8
Slide 10: Software Solutions as % of Software Revenue
Software Solutions as % of Software Revenue 2Q26 TTM Second Quarter Highlights Discovery ADMET Predictor® • 13 new clients • 10 upsells to existing clients Development GastroPlus® • 16 new clients • 6 upsells to existing clients MonolixSuite • 11 new clients • 7 upsells to existing clients Discovery
Slide 11: Software Performance Metrics - Q2 FY26
Software Performance Metrics - Q2 FY26 Commercial Clients Avg. Revenue per Client Renewal Rate* (in thousands) (fee based) *Excludes perpetual licenses for all periods 10
Slide 12: Software Performance Metrics - TTM
Software Performance Metrics - TTM Commercial Clients Avg. Revenue per Client Renewal Rate* Clients (in thousands) (fee based) (end of period) *Excludes perpetual licenses for all periods 11
Slide 13: Services Solutions as % of Services Revenue
Services Solutions as % of Services Revenue Q2 FY26 TTM Development Development Commercialization Commercialization 12
Slide 14: Services Performance Metrics Q2 FY26
Services Performance Metrics Q2 FY26 Total Projects Backlog (in millions) 13
Slide 15: Income Statement Summary - Q2 FY26
Income Statement Summary - Q2 FY26 (1) (in millions, except Diluted EPS and Adjusted Diluted EPS) 2Q26 % of Rev 2Q25 % of Rev Revenue $24.3 100% $22.4 100% Cost of revenue 8.1 34% 9.3 41% Gross profit 16.1 66% 13.1 59% R&D 3.5 14% 2.1 10% S&M 2.9 12% 3.7 17% G&A excluding nonrecurring 4.1 17% 4.5 20
Slide 16: Income Statement Summary - YTD FY26
Income Statement Summary - YTD FY26 (1) (in millions, except Diluted EPS and Adjusted Diluted EPS) FY26 % of Rev FY25 % of Rev Revenue $42.7 100% $41.4 100% Cost of revenue 15.7 37% 18.0 44% Gross profit 27.0 63% 23.3 56% R&D 6.5 15% 4.0 10% S&M 6.1 14% 6.6 16% G&A excluding nonrecurring 8.1 19% 9.4
Slide 17: Balance Sheet Summary
Balance Sheet Summary (1) (in millions) February 28, 2026 August 31, 2025 Cash and short-term investments $41.8 $32.4 Other current assets 25.7 19.2 Long term assets 78.9 80.4 Total assets $146.5 $131.9 Current liabilities 12.3 6.7 Long-term liabilities 0.4 0.4 Total liabilities 12.7 7.1 Shareholder
Slide 18: Fiscal 2026 Guidance
Fiscal 2026 Guidance Guidance Total Revenue $79M - $82M Total Revenue Growth 0% - 4% Software Revenue Mix 57% - 62% Adjusted EBITDA Margin (1) 26% - 30% Adjusted Diluted EPS (2) $0.75 - $0.85 (1) Adjusted EBITDA represents net income excluding the effect of interest expense (income), provision (bene
Slide 19: Adjusted EBITDA Non-GAAP Reconciliation
Adjusted EBITDA Non-GAAP Reconciliation (1) (in thousands) 2Q26 2Q25 FY26 YTD FY25 YTD Net income $4,535 $3,074 $5,211 $3,280 Excluding: Interest income and expense, net (288) (154) (555) (313) Provision for income taxes 1,351 434 1,645 498 Depreciation and amortization 1,547 2,274 2,893 4,539 Stock
Slide 20: Adjusted Diluted EPS Non-GAAP Reconciliation
Adjusted Diluted EPS Non-GAAP Reconciliation (1) (in thousands, except Diluted EPS and Adjusted Diluted EPS) 2Q26 2Q25 FY26 YTD FY25 YTD Net income $4,535 $3,074 $5,211 $3,280 Excluding: Amortization 1,460 2,130 2,719 4,260 Stock-based compensation 1,503 1,557 2,968 3,146 Loss on currency exchange 3
Slide 21: Thank You
Thank You Investor Relations Contact: Lisa Fortuna Financial Profiles slp@finprofiles.com | +1-310-622-8251